权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Smart web-based medical viewer for AI-based for EGFR mutation detection

基于网络的智能医疗查看器，用于基于 AI 的 EGFR 突变检测

基本信息

批准号：
10050399
负责人：
金额：
$ 6.37万
依托单位：
PRECIOUS MD LTD
依托单位国家：
英国
项目类别：
Grant for R&D
财政年份：
2023
资助国家：
英国
起止时间：
2023 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=10050399
关键词：
Smart web based medical viewer

项目摘要

Dr. Fatemeh Ameri is the current CEO of Precious MD, a medical technology firm specialising in providing non-invasive, AI powered solutions for detection of gene mutations in lung cancer.She has backgrounds in Computer engineering, Electronic commerce and Marketing. She received her PhD in Business and Management from University of Manchester in 2015 and became a lecturer (assistant professor) in Marketing at Manchester Business School right after. Her university research were primarily focused on business models of online health service providers, Online health information and Commercialization of biomedical technologies.Having accumulated the necessary knowledge in academia for nearly 4 years as a lecturer and researcher, she embarked on a journey to pursue her aspirations in entrepreneurship.Whilst keeping her contacts with the University of Manchester, she moved to Cambridge to expand her network and foster mutual relationships with new innovators, start-ups, medical practitioners and investors. To craft a viable business opportunity, she learned and understood the state-of -the-art rends in AI and medicine through consulting the literature and communication with key opinion leaders of both fields.She then founded PreciousMD in 2019, an AI driven medical image analytic firm. Her current goal at Precious MD is to develop a robust and accurate method for detection of certain gene mutations (epidermic growth factor receptor or EGFR) in lung cancer utilising solely AI and patients' CT (Computed Tomography) images.

Fatemeh Ameri博士是Precious MD的现任首席执行官，Precious MD是一家医疗技术公司，专门提供非侵入性的人工智能解决方案，用于检测肺癌基因突变。她拥有计算机工程，电子商务和市场营销的背景。她于2015年获得曼彻斯特大学商业与管理博士学位，并在曼彻斯特商学院担任市场营销讲师（助理教授）。她的大学研究主要集中在在线健康服务提供商的商业模式，在线健康信息和生物医学技术的商业化。她在学术界积累了近4年的讲师和研究人员的必要知识，开始了追求创业抱负的旅程。同时，她与曼彻斯特大学保持联系，她搬到了剑桥，以扩大她的网络，并促进与新的创新者，初创企业，医疗从业者和投资者的相互关系。为了创造一个可行的商业机会，她通过查阅文献和与两个领域的主要意见领袖交流，学习和理解了人工智能和医学的最新趋势。然后，她于2019年创立了PreciousMD，这是一家人工智能驱动的医学图像分析公司。她目前在Precious MD的目标是开发一种强大而准确的方法，仅利用AI和患者的CT（计算机断层扫描）图像检测肺癌中的某些基因突变（表皮生长因子受体或EGFR）。